EyeGate Pharmaceuticals I... (EYEG)

NASDAQ: EYEG · Real-Time Price · USD

35.26

0.00 (0.00%)

At close: Apr 28, 2025, 3:07 PM

EyeGate Pharmaceuticals Revenue

EyeGate Pharmaceuticals reported an annual revenue of $16.02M, reflecting a 0% growth. For the quarter ending September 30, 2024, EyeGate Pharmaceuticals generated $0 in revenue.

Revenue (ttm)

$16.02M

Revenue Growth

Price / Sales Ratio

8.46

Revenue / Employee

$1.14M

Employees

Market Cap

26.71M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	% Change
Dec 31, 2024	16.02M	+132746.84%
Dec 31, 2020	12.06K	n/a

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.